ABSTRACT
Background
The Human Respiratory Tract (HRT) is colonized by various microbial taxa, known as HRT microbiota, in a manner that is indicative of mutualistic interaction between such microorganisms and their host.
Aim
To investigate the microbial composition of the HRT and its possible correlation with the different compartments of the respiratory tract.
Methods
In the current study, we performed an in-depth meta‐analysis of 849 HRT samples from public shotgun metagenomic datasets obtained through several distinct collection methods.
Results
The statistical robustness provided by this meta-analysis allowed the identification of 13 possible HRT-specific Community State Types (CSTs), which appear to be specific to each anatomical region of the respiratory tract. Furthermore, functional characterization of the metagenomic datasets revealed specific microbial metabolic features correlating with the different compartments of the respiratory tract.
Conclusion
The meta-analysis here performed suggested that the variable presence of certain bacterial species seems to be linked to a location-related abundance gradient in the HRT and seems to be characterized by a specific microbial metabolic capability.
KEYWORDS: Human respiratory tract, oral microbiota, pulmonary, microbiome, shotgun metagenomics, sputum
Introduction
The human body harbors a large number of microorganisms that live in a close symbiotic relationship with their host, constituting a complex ecological community known as the microbiota [1]. An increasing number of studies have reported on the roles exerted by the human microbiota in maintaining physiological homeostasis of the host [2,3], modulating immunological [4,5], metabolic [6,7], and nutritional [8–10] functionalities. Moreover, specific microbiota compositions have been identified for particular anatomical body sites, including the gastrointestinal tract [11–13], the skin [14,15], vagina [16,17], and the respiratory tract [18,19]. Interestingly, for a long time, the Human Respiratory Tract (HRT) had erroneously been considered microbiologically sterile; it was modern metagenomic approaches through which in depth investigations of HRT’s microbial communities have been made possible [18,20].
The HRT can be divided into the Upper Respiratory Tract (URT), which includes the nasal cavity, pharynx, and larynx, and the Lower Respiratory Tract (LRT), which comprises the trachea, the primary bronchi, and lungs [18]. Many studies assessing the HRT microbiota have focused on specific regions, i.e. URT or LRT, with their associated microbiota composition being delineated using distinct sampling approaches, such as nasal [21–23] or lung lavage fluid [24,25], local swabs [26,27], biopsies [26,28] or sputum [29–31].
Microbiota-based studies targeting healthy individuals based on culture-independent methods has revealed that the LRT microbiota shares microbial colonizers with the URT microbiota [32,33] and that the oropharynx appeared to be the major bacterial source of the whole lung microbiota in adults [32,34]. Furthermore, culture-independent approaches, e.g. 16S rRNA gene sequencing, facilitated disentanglement of the complexity of microbial communities at genus-level resolution, revealing that the HRT microbiota composition is dominated by members of the Prevotella, Streptococcus, Veillonella, Pseudomonas, Fusobacterium, Haemophilus, and Neisseria genera [20,35]. Besides, relationships between microbiota composition and respiratory diseases were investigated, disclosing a low load and higher biodiversity of bacterial communities in healthy subjects when compared to those associated with certain diseases, some of which not being directly associated with bacterial infections, such as asthma [36], chronic obstructive pulmonary disease (COPD) [37] and cystic fibrosis [38,39].
Nevertheless, most of the currently available knowledge about the HRT microbiota is based on 16S rRNA gene sequencing analysis, thus restricting their taxonomic accuracy down to mostly genus level [40,41]. Moreover, currently published information pertaining to the HRT microbiota is generally aimed at identifying correlations between the HRT microbiota composition and HRT-associated diseases, thus targeting specific compartments of the respiratory tract, such as nasal cavity, larynx, or lung [21,42–46]. HRT surrogates, such as induced sputum and sputum, were also used to evaluate the upper and/or lower respiratory tract microbiota [29,47,48]. However, profiling of the lower respiratory tract microbiota through sputum and induced sputum samples may lead to taxonomical bias due to contamination of bacteria from the upper respiratory tract [49].
In order to provide a comprehensive view of the taxonomic composition of the HRT microbiota down to species level and to identify HRT-specific Community State Types (CSTs), we performed an in‐depth meta‐analysis of 16 publicly available shotgun metagenomic datasets corresponding to 849 samples obtained through different collection methods, i.e. lavage, swab, biopsy, and sputum, from healthy and diseased subjects [50–59]. Furthermore, the shotgun metagenomic data sets included in this study were further examined in order to dissect the genetic repertoire and microbial metabolic potential associated with such predicted HRT-CSTs.
Materials and methods
Database selection
In this meta-analysis-based study, we retrieved 16 publicly available data sets from studies involving the taxonomic determination of the human respiratory tract microbiome, performed in accordance with the relevant guidelines and regulations. In order to reduce the variability of the input data, we selected shotgun metagenomic datasets obtained by an Illumina sequencing platform. In detail, we selected shotgun metagenomic data sets from 849 samples from healthy or diseased subjects covering eight geographical regions (Table 1). The retrieved samples represented different collection methods, i.e. lavage, swabs, biopsies and sputum, from different HRT compartments (Supplementary Table S1).
Table 1.
Bioproject | PMID | Nation | No. of samples | Nasal lavage | Nasopharynx swab | Sputum | Cough swabs | Oropharynx swab | Lung lavage | Biopsy | Undefined Swab |
---|---|---|---|---|---|---|---|---|---|---|---|
PRJEB28158 | - | Germany | 207 | 86 | - | 55 | 66 | - | - | - | - |
PRJEB9034 | 26,872,143 | UK | 18 | - | - | 18 | - | - | - | - | - |
PRJNA71831 | 28,158,639 | USA | 4 | - | - | 4 | - | - | - | - | - |
PRJNA644285 | 33,262,957 | Brazil | 3 | - | - | 3 | - | - | - | - | - |
PRJNA655567 | - | China | 61 | - | - | - | - | - | 53 | - | 8 |
PRJNA659860 | - | Russia | 14 | - | - | - | - | - | 14 | - | - |
PRJNA682527 | - | Russia | 25 | - | - | - | - | - | - | 25 | - |
PRJNA258008 | - | USA | 14 | - | - | - | - | - | 13 | 1 | - |
PRJNA316056 | 28,758,937 | Italy | 12 | - | - | 12 | - | - | - | - | - |
PRJNA316588 | 28,187,782 | Switzerland | 18 | - | - | 18 | - | - | - | - | - |
PRJNA494034 | 32,580,896 | USA | 12 | - | - | - | - | - | 12 | - | - |
PRJNA510441 | - | USA | 1 | - | - | 1 | - | - | - | - | - |
PRJNA413615 | 31,367,746 | China | 334 | - | 42 | - | - | 246 | 46 | - | - |
PRJNA516870 | 32,635,564 | Italy | 22 | - | - | 22 | - | - | - | - | - |
PRJNA516442 | 30,784,601 | USA | 11 | - | - | 11 | - | - | - | - | - |
PRJEB38221 | 33,319,812 | Germany | 93 | - | - | - | 93 | - | - | - | - |
Taxonomic classification of sequence reads
Taxonomic profiling of sequenced reads was performed employing the METAnnotatorX2 bioinformatics platform [60,61]. In detail, the downloaded fastq files were filtered to remove reads with a quality of <25, and to retain reads with a length of >100 bp. Subsequently, a human host DNA filtering was performed through bowtie2 software [62,63], following the METAnnotatorX2 manual [61]. Afterwards, taxonomic classification of 100,000 reads was achieved by means of MegaBLAST [64] employing a manually curated and pre-processed database of genomes retrieved from the National Center for Biotechnology Information (NCBI), following the METAnnotatorX2 manual [61].
Functional prediction
Functional profiling of the sequenced reads was performed with the METAnnotatorX2 bioinformatics platform [60,61]. Functional classification of reads was performed to reveal metabolic pathways based on the MetaCyc database (release 24.1) [65] through RAPSearch2 software [66,67].
Human respiratory tract Community State Type (HRT-CST) prediction
The HCL of samples was obtained using bacterial composition at species level and was calculated through ORIGIN 2021 (https://www.originlab.com/2021) software using Pearson correlation as a distance metric based on information at species level. The data obtained was represented by a cladogram.
Statistical analysis
ORIGIN 2021 (https://www.originlab.com/2021) and SPSS software (www.ibm.com/software/it/analytics/spss/) were used to compute statistical analyses, including HCL and Silhouette analyses. EMPeror tool was used to visualize PCoA analyses [68] calculated through ORIGIN 2021. PERMANOVA analyses were performed using 1,000 permutations to estimate p-values for differences among populations in PCoA analyses. Furthermore, differential abundance of bacterial genera was tested by t-test or Mann–Whitney U test analysis. Multiple comparison analyses were performed through Tukey’s HSD (honestly significant difference) test. Moreover, multivariate analyses were performed through MaAsLin2 software [69].
Results
Dataset selection
In order to retrieve all publicly available metagenomic data sets concerning studies related to HRT microbiota, an extensive scientific literature search was performed (Figure S1). The scientific literature examination allowed us to collect HRT microbiota data from 16 publicly available data sets based on Illumina shotgun metagenomic methodologies, encompassing individuals from eight different countries (Figure S1, Table 1, and Supplementary Table S1). In detail, the multi-population cohort meta-analysis presented in this study includes datasets corresponding to a total of 849 samples from healthy or diseased subjects, obtained through different collection methods, i.e. lavage, swab, biopsy, and sputum (Table S1).
Identification of human respiratory tract Community State Types (HRT-CSTs)
A total of 849 publicly available shotgun metagenomic datasets representing the HRT microbiota, including upper and lower respiratory tract, were collected. As reported in previous studies regarding human-associated microbiota, we employed a large number of HRT samples to aim for robust statistical accuracy [17,70–72]. In detail, we focused on samples obtained through Illumina shotgun sequencing to accurately profile bacteria at species level through re-analysis with the METAnnotatorX2 platform [60,61].
Quality filtering and human DNA read-removal were performed starting from the collected fastq files and resulting in a total of 432,176 Mbp with an average of 1,002 ± 1,682 Mbp per sample (Table S1). The collected data sets were employed to predict the existence of common HRT-associated taxonomic profile patterns, leading to the identification of so-called HRT-CSTs. Identification of the minimal number of clusters necessary to define such HRT-CSTs was achieved by an unsupervised Silhouette method, revealing an optimal number of seven clusters (Figure S2a). Subsequently, a supervised cluster analysis through Hierarchical CLustering (HCL), involving the microbial taxonomic profiles at species level of HRT samples (Figure 1(a)), was performed to implement and biologically verify the results of the unsupervised approach, while also being supported by 3D Bray Curtis PCoA (Figure 1(b)). In detail, putative HRT-CSTs were defined by clusters represented by at least 1% of the total sample number, i.e. eight samples, and by samples from at least two different datasets to exclude possible biases related to a single study, as previously reported [73]. The validity of identified clusters was statistically confirmed by PERMANOVA (p-value < 0.05) based on PCoA analysis (Figure 1(b)). Furthermore, in order to exclude possible extrinsic bias, PCoA analyses were performed to identify possible associations between microbiota composition of each sample and the corresponding bioproject study or geographic origin (Figure S2a and b), revealing the absence of specific cluster and an heterogeneous distribution of samples.
The metagenomic meta-analysis of HRT samples allowed us to identify a total of 13 distinct CSTs (Figure 1(a) and Table 2), mainly characterized by species belonging to the Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria phyla. Moreover, each identified CST was defined by the most abundant taxa with a prevalence > 85% (Table 2), while the remaining bacteria identified for each CST were considered accessory taxa. In detail, the meta-analysis revealed that the most prevalent CST of the HRT was HRT-CST-Ss (represented by 11% of the total number of samples) and HRT-CST-Rm (9% of the total sample number), which are dominated by Streptococcus salivarius and Rothia mucilaginosa, respectively (Table 2). Besides, five HRT-CSTs characterized by species belonging to the Staphylococcus and Prevotella genera were shown to be present at a prevalence ranging from 9% to 3%, and were defined as HRT-CST-Se, HRT-CST-Sa, HRT-CST-Pj, HRT-CST-Pm and HRT-CST-Ph, being characterized by a high relative abundance of Staphylococcus epidermidis, Staphylococcus aureus, P. jejuni, P. melaninogenica and P. histicola, respectively (Table 2). Furthermore, the meta-analysis allowed us to distinguish seven HRT-CSTs with a low prevalence (≤ 6% of the total sample) and typified by the presence of bacterial species considered opportunistic pathogens (Table 2). In detail, the latter were characterized by Neisseria subflava (HRT-CST-Ns), Streptococcus mitis (HRT-CST-Sm), Haemophilus influenzae (HRT-CST-Hi), Tetrasphaera japonica (HRT-CST-Tj), Pseudomonas aeruginosa (HRT-CST-Pa), and Corynebacterium propinquum (HRT-CST-Cp) (Table 2). Additionally, the HCL analysis revealed two clusters representing putative CSTs characterized by an unknown species belonging to the Pasteurella genus (Cluster-P) or Schaalia genus (Cluster-S) (Figure 1(a)). The predominance of sequences not associated with defined bacterial species indicates a non-specific classification with the consequent definition of putative HRT-CSTs, which are not associated with the presence of particular species. In order to define possible representative species of these two putative clusters, de novo assemblies through METAnnotatorX2 platform [60,61] were performed. Nevertheless, the high contamination of eukaryotic DNA and the low amount of bacterial reads did not allow to obtain reliable results. Moreover, Cluster-S appears to be characteristic of only one specific bioproject, i.e. PRJNA413615. For these reasons, Cluster-P and Cluster-S were excluded from HRT-CSTs classification and subsequent analyses. In this context, the biopsy samples displayed the lowest number of microbial profiles at a taxonomic resolution down to species level, being mainly represented by unknown species of Pasteurella, Pseudomonas, and Tetrasphaera genera. Consequently, due to the low number of samples and being derived mainly from a single bioproject (Table 1), biopsy samples were excluded from further analyses regarding the correlation between microbiota composition and anatomical body sites. Indeed, further studies involving a higher number of biopsy samples are needed to extend our comprehension of the microbial communities that adhere to pulmonary tissues.
Table 2.
HRT-CSTs |
Prevalence over the total |
|
Streptococcus salivarius |
Prevotella jejuni |
Rothiamucilaginosa |
Staphylococcus epidermidis |
Neisseria subflava |
Prevotella melaninogenica |
Streptococcus mitis |
Staphylococcus aureus |
Haemophilus influenzae |
Prevotella histicola |
Pseudomonas aeruginosa |
Tetrasphaera japonica |
Corynebacterium propinquum |
HRT-CST-Ss | 11% | Average | 10.43% | 0.81% | 5.59% | 0.49% | 0.54% | 3.06% | 3.51% | 1.12% | 0.25% | 2.05% | 0.75% | 0.21% | 0.08% |
Prevalence | 92% | 41% | 92% | 5% | 19% | 63% | 79% | 11% | 9% | 51% | 10% | 7% | 2% | ||
HRT-CST-Pj | 9% | Average | 2.68% | 9.11% | 1.10% | 0.00% | 2.29% | 8.95% | 2.52% | 0.11% | 0.03% | 6.37% | 0.00% | 0.01% | 0.00% |
Prevalence | 81% | 100% | 64% | 0% | 73% | 100% | 84% | 3% | 1% | 95% | 0% | 1% | 0% | ||
HRT-CST-Rm | 9% | Average | 2.61% | 0.26% | 28.08% | 0.21% | 3.02% | 1.40% | 3.17% | 0.76% | 0.18% | 0.95% | 0.67% | 0.13% | 0.03% |
Prevalence | 69% | 16% | 100% | 4% | 50% | 54% | 66% | 9% | 5% | 32% | 7% | 8% | 1% | ||
HRT-CST-Se | 7% | Average | 1.09% | 0.03% | 0.65% | 50.12% | 0.17% | 0.09% | 1.46% | 2.70% | 0.57% | 0.03% | 0.90% | 1.92% | 0.24% |
Prevalence | 23% | 4% | 18% | 100% | 7% | 7% | 30% | 29% | 18% | 2% | 25% | 41% | 5% | ||
HRT-CST-Ns | 6% | Average | 1.17% | 1.78% | 3.80% | 0.00% | 9.26% | 6.53% | 3.50% | 0.07% | 0.02% | 1.17% | 0.00% | 0.13% | 0.00% |
Prevalence | 48% | 65% | 96% | 0% | 100% | 100% | 87% | 4% | 2% | 52% | 0% | 8% | 0% | ||
HRT-CST-Pm | 6% | Average | 2.89% | 2.09% | 2.59% | 0.03% | 2.72% | 18.45% | 3.12% | 0.75% | 0.07% | 4.20% | 0.03% | 0.42% | 0.00% |
Prevalence | 63% | 88% | 79% | 2% | 73% | 100% | 79% | 4% | 6% | 71% | 2% | 12% | 0% | ||
HRT-CST-Sm | 6% | Average | 1.56% | 1.02% | 2.22% | 0.31% | 1.54% | 2.38% | 22.59% | 0.03% | 1.13% | 0.86% | 0.00% | 0.11% | 0.00% |
Prevalence | 60% | 28% | 74% | 4% | 40% | 70% | 100% | 4% | 30% | 28% | 0% | 10% | 0% | ||
HRT-CST-Sa | 6% | Average | 1.14% | 0.10% | 1.44% | 1.33% | 0.07% | 0.40% | 1.49% | 59.58% | 0.29% | 0.42% | 2.27% | 0.96% | 0.43% |
Prevalence | 33% | 6% | 38% | 25% | 4% | 19% | 33% | 100% | 8% | 8% | 27% | 17% | 4% | ||
HRT-CST-Hi | 3% | Average | 2.56% | 0.59% | 1.20% | 1.64% | 0.53% | 0.91% | 2.93% | 0.85% | 51.04% | 1.85% | 0.00% | 0.74% | 0.35% |
Prevalence | 59% | 31% | 45% | 17% | 24% | 48% | 59% | 7% | 100% | 38% | 0% | 31% | 3% | ||
HRT-CST-Ph | 3% | Average | 2.93% | 2.79% | 1.76% | 0.05% | 1.15% | 5.99% | 3.10% | 0.07% | 0.15% | 16.42% | 0.06% | 0.18% | 0.00% |
Prevalence | 70% | 74% | 74% | 4% | 44% | 93% | 74% | 4% | 4% | 100% | 4% | 15% | 0% | ||
HRT-CST-Pa | 2% | Average | 1.28% | 0.41% | 1.97% | 0.00% | 0.00% | 0.56% | 0.80% | 2.14% | 0.00% | 0.63% | 55.84% | 2.37% | 0.00% |
Prevalence | 24% | 19% | 38% | 0% | 0% | 29% | 29% | 24% | 0% | 24% | 100% | 38% | 0% | ||
HRT-CST-Tj | 2% | Average | 0.00% | 0.84% | 0.00% | 0.00% | 0.25% | 1.94% | 1.59% | 0.00% | 0.00% | 0.00% | 0.15% | 41.09% | 0.00% |
Prevalence | 0% | 11% | 0% | 0% | 6% | 22% | 11% | 0% | 0% | 0% | 6% | 100% | 0% | ||
HRT-CST-Cp | 1% | Average | 0.42% | 0.00% | 0.08% | 2.04% | 1.69% | 0.00% | 0.00% | 2.63% | 1.42% | 0.00% | 0.00% | 4.24% | 50.97% |
Prevalence | 13% | 0% | 13% | 38% | 25% | 0% | 0% | 25% | 13% | 0% | 0% | 63% | 100% |
In red are highlighted the relative abundances > 9%, while in green are selected prevalence > 85%
Correlation between HRT microbiota and human body-anatomical regions
The identification of specific HRT-CSTs representative of the respiratory tract as a single compartment suggested to investigate possible correlations between the specific respiratory compartments, such as lung, throat and nasal cavity, and the HRT-CSTs. In detail, the high number of samples included in the meta-analysis allowed us to explore possible correlations between the HRT microbiota composition and different sampling methods, i.e. lavage, swab, and sputum.
Analysis of HRT-CSTs’ prevalence showed that all HRT-CSTs encompass samples of at least two different sampling methodologies and represent a common microbial community profile of distinct compartments of the respiratory tract (Figure 2(a)) [32,33]. Moreover, samples from the nasal cavity, i.e. nasal lavage and nasopharynx swab, were shown to exhibit a high prevalence of HRT-CST-Se (prevalence of 34% and 38%, respectively). Furthermore, the analyzed oropharynx samples showed a high prevalence of HRT-CST-Pj (28%), while cough swabs were demonstrated to exhibit a high prevalence of HRT-CST-Rm (22%) and HRT-CST-Sm (22%) (Figure 2(a)). In contrast, sputum and lung lavage samples revealed a variable microbiota composition, showing the absence of any specific HRT-CST related to any of these two compartments (Figure 2(a)). Analysis of the beta-diversity represented through Bray Curtis 3D-PCoA (Figure 2(b)) revealed three specific clusters independent of the sampling methods but related to particular respiratory tract compartments, i.e. nasal cavity, throat, and lung, thus indicating taxonomic features specific to each of these anatomic regions PERMANOVA (p-value < 0.05). Conversely, sputum samples elicited a heterogeneous microbial distribution and therefore a more variable sputum microbiota composition (Figure 2(b)).
Consequently, we decided to investigate the presence of specific bacterial communities associated with specific HRT compartments. In detail, we focused on 53 bacterial species with a relative abundance > 1% in at least one compartment group (Table S2). In detail, nasal cavity, throat, and lung compartments shared a total of 40 microbial species (Table S2), highlighting common microbial community inhabitants of different compartments of the respiratory tract. Moreover, samples from the nasal cavity presented a high prevalence and relative abundance of Staphylococcus epidermidis (Table S2 and Figure 3(a)). It is possible that Staphylococcus epidermidis as a common component of the nasal microbiome plays a major role in promoting ecological competition between commensal bacteria and opportunistic pathogenic species, as reported previously [74,75]. Interestingly, the presence of skin-colonizing bacteria such as Staphylococcus epidermidis indicates a relationship between the microbiota of the nasal cavity and that of the skin, suggesting a bacterial transition between these ecological niches. Additionally, in the other assessed HRT compartments, i.e. throat and lung, Staphylococcus epidermidis is present at a lower relative abundance than the nasal cavity, probably reflecting a decreasing abundance gradient based on distance from the nasal cavity (Figure 3(b)). Besides, seven other species, including Haemophilus influenzae and Streptococcus pneumoniae, are shared among the different body-compartments and were shown to be present at a decreasing abundance gradient depending on the distance from the nasal cavity (Figure 3(b)). Intriguingly, a specific multivariate analysis through MaAslin2 software [69] and based on sampling methods, HRT-CSTs, bioproject, and geographical origin, revealed that among the taxa characterizing each CST, S. epidermidis, H. influenzae and Str. pneumoniae possessed the largest number of significant negative associations (all false discovery rate (FDR) < 0.05) with the HRT-CSTs (Figure 3(c) and Table S3). These results could suggest an high ability of these bacterial species to compete for their specific ecological niche. Furthermore, throat, i.e. cough and oropharynx swabs, sputum and lung lavage samples were shown to exhibit heterogeneous microbial compositions, without a predominant taxon, perhaps representing a transitory microbiota. Intriguingly, the throat microbiota appears to be characterized by species belonging to the genera Streptococcus and Rothia [76], such as Streptococcus parasanguinis, Streptococcus salivarius and R. mucilaginosa, which are also representatives of the sputum microbiota (Table S3), indicate a tight transition of bacteria between these two body-compartments. In accordance with these results, the multivariate analysis of these taxa revealed a limited number of significant associations, probably indicating these species as components of a transient microbiota (Table S3). In addition, sputum and lung lavage samples revealed a specific taxonomical gradient based on distance from each compartment (Figure 3b). In detail, lung lavage samples showed five bacterial species, such as Tetrasphaera japonica, with a higher relative abundance compared to other compartments, indicating a possible increasing gradient (Figure 3(b)). In contrast, sputum samples revealed six species, represented by Pseudomonas aeruginosa, Streptococcus parasanguinis, Streptococcus salivarius, Streptococcus oralis, Rothia dentocariosa, and Veillonella parvula, with a distance-dependent gradient from the oral cavity, possibly reflecting bacterial adaptation to a specific ecological niche.
Association between HRT-CSTs and respiratory tract disease
The samples involved in this meta-analysis include both healthy and diseased samples (Table S1). In fact, the main purpose of this study was to assess the HRT microbiota regardless of host health status. Nevertheless, we explored the statistical power of this meta-analysis to identify correlations between HRT-CSTs and respiratory tract disease. Unfortunately, the absence of comprehensive metadata regarding the classification of the pulmonary pathology prevented detailed comparisons between healthy and diseased samples and identifying the possible correlations between HRT microbiota composition and specific pulmonary diseases. In detail, this analysis highlighted that diseased samples appeared to be associated with five HRT-CSTs, i.e. HRT-CST-Hi, HRT-CST-Tj, HRT-CST-Se, HRT-CST-Pa, and HRT-CST-Sa, with a prevalence > 90% (Figure 4(a)). In contrast, only HRT-CST-Pj is associated with healthy samples (prevalence = 93%) (Figure 4(a)). Furthermore, analysis of species richness revealed a lower complexity of the diseased samples (species richness of 31 ± 12) compared to samples obtained from healthy subjects (species richness of 17 ± 12) (p-value < 0.05) (Figure 4(b)). These data indicate a correlation between simplification of the HRT microbiota and (the onset of) respiratory disorders, possibly due to the predominance of opportunistic bacteria, such as Haemophilus influenzae, Pseudomonas aeruginosa, and Staphylococcus aureus [77–79]. In contrast, healthy samples possess a more heterogeneous microbiota with higher microbial biodiversity, confirming the concept that healthy subjects possess a more diverse bacterial HRT community that is considered to enjoy homeostasis [38]. Moreover, a specific multivariate analysis through MaAslin2 software [69] based on sampling methods as well as HRT-CSTs as well as bioproject, and geographical origin, revealed that the main significant correlations are positive and related to HRT-CSTs but with low model coefficient values (Figure 4(c) and Table S4), suggesting an absence of correlation with the HRT community state types. Notably, the multivariate analysis highlighted the absence of correlations with the health status of the respiratory tract, but this result could be influenced by the type of distribution of the diseased samples (Figure 4(b)). Certainly, further analyses focused on the investigation of bacterial differences between different respiratory tract diseases and healthy individuals are necessary to elucidate the role and/or the association of the HRT with the onset of respiratory pathologies.
Functional capabilities based on anatomical human body regions
The specific microbial community profiles of different body compartments are assumed to correspond to specific microbiomes and genetic repertoires. In order to explore the genetic features characterizing each HRT compartment, we performed a screening of metabolic pathways based on the MetaCyc database [65]. This metabolic analysis included all HRT samples except biopsy samples. In fact, biopsy samples after human-DNA filtering did produce enough microbial DNA data to perform the metabolic analysis. Therefore, evaluation of enzyme classes based on Enzyme Commission (EC) number revealed differences in the relative abundance of predicted enzyme functions between different respiratory compartments. In detail, samples from the nasal cavity and lung lavage showed the highest abundance of oxidoreductases (average abundance 19.60% ± 1.62% and 17.43% ± 3.65%, respectively) when compared to other HRT compartments (ANOVA p-value < 0.01, Tukey’s HSD post-hoc test p-value < 0.01) (Figure 5(a)). Similarly, analysis based on HRT-CSTs with a prevalence of > 3% revealed that HRT-CST-Se and HRT-CST-Sa, being the main representatives of the nasal tract and lung lavage, respectively, reflected the enzyme class abundance-trend of the respiratory tract compartments (Figure 5(b)). These results highlight a metabolic adaptation by bacterial communities based on their ecological niche and/or type of sampling. In detail, nasal cavity and lung lavage samples revealed a total of 21 EC oxidoreductase sub-classes with the highest significant relative abundance compared to other HRT compartments (Tukey’s HSD post-hoc test p-value < 0.01), including enzymes predicted to be responsible for formation of nitric oxide, e.g. nitrite reductase (EC 1.7.1.4) and nitric-oxide synthase (EC 1.14.13.39), and in the production of lactate, e.g. D- and L-lactate dehydrogenase (EC 1.1.1.28 and 1.1.1.27, respectively) (Table S5). These results are confirmed by the multivariate analysis calculated through MaAslin2 software [69], which revealed a significant negative correlation between EC 1.7.1.4 and 1.1.1.28 with sputum and throat samples (Figure 5(c) and Table S6). In detail, nitric oxide is reported to exert an important physiological role in the regulation of pulmonary vasomotor tone [80,81] and an increase of enzymes involved in this metabolic pathway validates the mutualistic interaction between HRT microorganisms and their host. Moreover, the predicted higher abundance of enzymes involved in lactate production indicates the importance of certain bacteria in keeping the nasal environment at a relatively low pH, thereby supporting antimicrobial effects [82]. Furthermore, focusing on EC sub-classes specific for each HRT compartment, lung lavage samples showed an increase of 155% of Cd(2+)-exporting ATPase (EC 7.2.2.21) when compared to other HRT compartments (Tukey’s HSD post-hoc test p-value < 0.01) (Table S5). This enzyme is involved in heavy metal detoxification [83], and its relatively high abundance in the lung suggests an ecological adaptation of bacteria to the pulmonary environment, perhaps due to the continuous intake of air pollutants [84,85]. In addition, sputum and throat samples revealed a higher abundance of enzymes involved in carbohydrate metabolism, e.g. glycogen phosphorylase (EC 2.4.1.1), alpha-amylase (EC 3.2.1.1), pullulanase (EC 3.2.1.41), and dextranase (EC 3.2.1.11), compared to other compartments, suggestive of an adaptation of bacterial communities to the oral environment that is involved in preliminary digestive processes [86,87]. The small presence of these enzymes in the others anatomic sites of lower respiratory tract could be explained by a partial contamination/transition of bacteria characterizing the oral microbiota to the sputum and throat compartments [43], but also could indicate a possible specific selective pressure from the specific respiratory anatomic sites [88].
An extensive analysis based on metabolic pathways prediction confirmed possible differences in relation to the different HRT compartments. In detail, the sputum samples presented a higher number of unique pathways, i.e. 237 pathways, respect to the throat samples, nasal cavity, and lung lavage that displayed 101, 86, and 95 unique pathways, respectively. Similarly, focusing on the degradation and biosynthesis pathways, the throat, nasal cavity, and lung lavage samples highlighted a similar number of unique pathways respect to sputum samples showed the highest number of unique pathways (Table S7). These results could confirm the adaptation of microbial communities to different ecological niches, highlighting the high metabolic commitment of the oral bacteria involved in several specific physiological activities, such as preliminary digestive processes, specific to HRT compartments.
Discussion
The HRT harbors a complex community of microorganisms, that are believed to play a major role in preserving physiological homeostasis of the host [18,89]. However, in contrast to the gastrointestinal tract, which represents the most thoroughly investigated organ-microbiota niche, the human respiratory tract remains relatively poorly investigated [90,91]. Despite several studies based on culture-independent metagenomic analyses aimed at evaluating the microbiota composition of different HRT sites, a comprehensive meta-analysis is still missing. Here, we collected a total of 849 HRT samples from publicly available shotgun metagenomic datasets, representing the respiratory tract as a single compartment and facilitating an in‐depth meta‐analysis. This statistically robust meta-analysis allowed us to identify 13 possible HRT-specific Community State Types (CSTs), mainly characterized by species belonging to Streptococcus, Staphylococcus, Prevotella, Neisseria, and Rothia genera. Furthermore, analysis of the distribution of each HRT-CSTs along the respiratory tract highlighted a possible specific microbial correlation with the different HRT compartments. In this context, our meta-analysis highlighted a location-specific abundance gradient in HRT of certain bacterial species, such as Staphylococcus epidermidis, Streptococcus salivarius, and Pseudomonas aeruginosa, reinforcing the notion of a possible bacterial adaptation to a specific ecological niche within the HRT. Such findings were further corroborated by metabolic reconstruction of metagenomic datasets from different HRT regions. Intriguingly, samples from the nasal cavity and lung lavage compared to those obtained from other HRT compartments showed statistically significant differences in the predicted microbial enzyme profiles, including metabolic pathways involved in nitric oxide and lactate production. These results suggest the existence of a correlation between the different compartments of the respiratory tract and highlight the important role that the HRT microbiota plays in maintaining host homeostasis. Conversely, sputum samples revealed a higher abundance of enzymes implicated in carbohydrate metabolism, revealing a possible metabolic adaptation of resident bacteria to specific ecological niches. Certainly, specific in vitro metabolism studies will be useful to provide further data on the effective metabolic capabilities of each HRT-CST.
Moreover, the lack of complete public metadata, such as gender, age, and diet, did not allow us to perform in depth multiple correlations with the composition of the HRT-CSTs microbiome. Remarkably, the predominance of data derived from samples associated with lung diseases when compared to healthy samples of certain HRT compartments, i.e. lavage samples, and the lack of in depth details on the type of pulmonary pathology, e.g. disease severity, very much limited our ability to perform meaningful comparisons between healthy and diseased samples. In this context, specific studies assessing bacterial differences between different lung diseases and healthy individuals using shotgun metagenomics approaches are expected to contribute to the identification of biomarkers that are involved in or associated with the onset of HRT pathologies.
Conclusion
In conclusion, our meta-analysis allowed the identification of 13 putative Community State Types (CSTs), which appear to correlate with the different HRT compartments. Moreover, several bacterial species display a location-specific abundance gradient in HRT, suggesting a possible bacterial adaptation to a specific HRT compartment. Furthermore, the metabolic reconstruction of HRT metagenomic datasets revealed significant differences in the predicted enzyme profiles, suggesting a potential role of the HRT microbiota in maintaining host homeostasis and confirming a possible metabolic adaptation of resident bacteria to specific ecological niches.
Supplementary Material
Acknowledgments
Part of this research is conducted using the High Performance Computing (HPC) facility of the University of Parma.
Funding Statement
This study was supported by “Programma Operativo Nazionale Ricerca eInnovazione” 2014-2020 (PON “R&I” 2014-2020) [project ARS01_00530] and by the extraordinary call of the University of Parma 2020 for biomedical research projects in the SARS-CoV-2 and COVID-19 field [project COVIDbiome]. FT was supported by PROGETTO Ricerca Finalizzata, Ministero della Salute [RF GR-2018-12365988]. DvS is a member of APC Microbiome Ireland funded by Science Foundation Ireland (SFI), through the Irish Government’s National Development Plan [Grant no’s. SFI/12/RC/2273-P1 and SFI/12/RC/2273-P2].
Disclosure statement
No potential conflict of interest was reported by the author(s).
Author contributions
L.M.: processed the metagenomic data, conducted and interpreted the analyses, and wrote the manuscript.
C.M.: participated in the study’s design and contributed to the manuscript preparation.
F.F.: contributed to the statistical analyses.
G.A.L.: contributed to the metagenomic analyses.
C.T.: contributed to the metagenomic analyses.
F.T.: Contributed to the conception and analysis of the study.
D.v.S.: participated, supervised, and critically revised the manuscript.
M.V.: conceived the study, participated in its design and coordination and contributed to the manuscript preparation.
All authors have read and approved the final manuscript.
Supplementary material
Supplemental data for this article can be accessed here.
References
- [1].Marchesi JR, Ravel J.. The vocabulary of microbiome research: a proposal. Microbiome. 2015;3(1):31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Dekaboruah E, Suryavanshi MV, Chettri D, et al. Human microbiome: an academic update on human body site specific surveillance and its possible role. Arch Microbiol. 2020;202(8):2147–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Eisenstein M. The skin microbiome and its relationship with the human body explained. Nature. 2020;588(7838):S210–S211. [DOI] [PubMed] [Google Scholar]
- [4].Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341–352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Cheng HY, Ning MX, Chen DK, et al. Interactions between the gut microbiota and the host innate immune response against pathogens. Front Immunol. 2019;10:607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Visconti A, Le Roy CI, Rosa F, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun. 2019;10(1):4505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Wang XQ, Zhang A-H, Miao J-H, et al. Gut microbiota as important modulator of metabolism in health and disease. Rsc Adv. 2018;8(74):42380–42389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Milani C, Ferrario C, Turroni F, et al. The human gut microbiota and its interactive connections to diet. J Hum Nutr Diet. 2016;29(5):539–546. [DOI] [PubMed] [Google Scholar]
- [9].Valdes AM, Walter J, Segal E, et al. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Kolodziejczyk AA, Zheng D, Elinav E. Diet-microbiota interactions and personalized nutrition. Nat Rev Microbiol. 2019;17(12):742–753. [DOI] [PubMed] [Google Scholar]
- [11].Moszak M, Szulinska M, Bogdanski P. You are what you eat-the relationship between diet, microbiota, and metabolic disorders-a review. Nutrients. 2020;12(4):1096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Manor O, Dai CL, Kornilov SA, et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020;11(1):5206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Mancabelli L, Milani C, Lugli GA, et al. Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses. Sci Rep. 2017;7(1):9879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143–155. [DOI] [PubMed] [Google Scholar]
- [16].Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4680–4687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Mancabelli L, Tarracchini C, Milani C, et al. Vaginotypes of the human vaginal microbiome. Environ Microbiol. 2021;23(3):1780–1792. [DOI] [PubMed] [Google Scholar]
- [18].Man WH, de Steenhuijsen Piters WA, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15(5):259–270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol. 2019;20(10):1279–1290. [DOI] [PubMed] [Google Scholar]
- [20].Dickson RP, Erb-Downward JR, Martinez FJ, et al. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78(1):481–504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Chen CH, Liou M-L, Lee C-Y, et al. Diversity of nasal microbiota and its interaction with surface microbiota among residents in healthcare institutes. Sci Rep. 2019;9(1):6175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Lehtinen MJ, Hibberd AA, Männikkö S, et al. Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge. Sci Rep. 2018;8(1):11411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Hsiao CJ, Paulson JN, Singh S, et al. Nasal microbiota and infectious complications after elective surgical procedures. JAMA Network Open. 2021;4(4):e218386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Lee SH, Sung JY, Yong D, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer. 2016;102:89–95. [DOI] [PubMed] [Google Scholar]
- [25].Schneeberger PHH, Prescod J, Levy L, et al. Microbiota analysis optimization for human bronchoalveolar lavage fluid. Microbiome. 2019;7(1):141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].Pragman AA, Lyu T, Baller JA, et al. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome. 2018;6(1):7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Gopinath D, Menon RK, Wie CC, et al. Differences in the bacteriome of swab, saliva, and tissue biopsies in oral cancer. Sci Rep. 2021;11(1):1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Yu G, Gail MH, Consonni D, et al. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol. 2016;17(1):163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Tangedal S, Nielsen R, Aanerud M, et al. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLoS One. 2019;14(9):e0222449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Li N, Qiu R, Yang Z, et al. Sputum microbiota in severe asthma patients: relationship to eosinophilic inflammation. Respir Med. 2017;131:192–198. [DOI] [PubMed] [Google Scholar]
- [31].Druzhinin VG, Matskova LV, Demenkov PS, et al. Taxonomic diversity of sputum microbiome in lung cancer patients and its relationship with chromosomal aberrations in blood lymphocytes. Sci Rep. 2020;10(1):9681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32].Segal LN, Alekseyenko AV, Clemente JC, et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome. 2013;1(1):19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33].Marsh RL, Kaestli M, Chang AB, et al. The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. Microbiome. 2016;4(1):37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [34].Segal LN, Clemente JC, Tsay J-CJ, et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. 2016;1(5):16031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [35].Beck JM, Young VB, Huffnagle GB. The microbiome of the lung. Transl Res. 2012;160(4):258–266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [36].Barcik W, Boutin RCT, Sokolowska M, et al. The role of lung and gut microbiota in the pathology of asthma. Immunity. 2020;52(2):241–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37].Chiu YC, Lee SW, Liu CW, et al. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study. Respir Res. 2022;23(1):10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [38].Santacroce L, Charitos IA, Ballini A, et al. The human respiratory system and its microbiome at a glimpse. Biology (Basel). 2020;9. DOI: 10.3390/biology9100318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [39].Broderick DTJ, Regtien T, Ainsworth A, et al. Dynamic upper and lower airway microbiotas in paediatric bronchiectasis exacerbations: a pilot study. Front Cell Infect Microbiol. 2021;11:773496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [40].Earl JP, Adappa ND, Krol J, et al. Species-level bacterial community profiling of the healthy sinonasal microbiome using Pacific Biosciences sequencing of full-length 16S rRNA genes. Microbiome. 2018;6(1). DOI: 10.1186/s40168-018-0569-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [41].Johnson JS, Spakowicz DJ, Hong B-Y, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 2019;10(1):5029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [42].Biswas K, Hoggard M, Jain R, et al. The nasal microbiota in health and disease: variation within and between subjects. Front Microbiol. 2015;9:134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [43].Gong H, Shi Y, Zhou X, et al. Microbiota in the throat and risk factors for laryngeal carcinoma. Appl Environ Microbiol. 2014;80(23):7356–7363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [44].Gong HL, Shi Y, Zhou L, et al. The composition of microbiome in larynx and the throat biodiversity between laryngeal squamous cell carcinoma patients and control population. PLoS One. 2013;8(6):e66476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [45].Gomes S, Cavadas B, Ferreira JC, et al. Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma. Sci Rep. 2019;9(1):12838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [46].Ramirez-Labrada AG, Isla D, Artal A, et al. The influence of lung microbiota on lung carcinogenesis, immunity, and immunotherapy. Trends Cancer. 2020;6(2):86–97. [DOI] [PubMed] [Google Scholar]
- [47].Millares L, Pascual S, Montón C, et al. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients. BMC Pulm Med. 2019;19(1):112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [48].Huang YJ, Sethi S, Murphy T, et al. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol. 2014;52(8):2813–2823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [49].Leiten EO, Nielsen R, Wiker HG, et al. The airway microbiota and exacerbations of COPD. ERJ Open Res. 2020;6(3):00168–2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [50].Cameron SJS, Lewis KE, Huws SA, et al. Metagenomic sequencing of the chronic obstructive pulmonary disease upper bronchial tract microbiome reveals functional changes associated with disease severity. PLoS One. 2016;11(2):e0149095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [51].Westbrook A, Ramsdell J, Schuelke T, et al. PALADIN: protein alignment for functional profiling whole metagenome shotgun data. Bioinformatics. 2017;33(10):1473–1478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [52].de Almeida OGG, Carolina Paulino da Costa C, Tonani L, et al. The lung microbiome of three young brazilian patients with cystic fibrosis colonized by fungi. Front Cell Infect Microbiol. 2020;10:598938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [53].Bacci G, Mengoni A, Fiscarelli E, et al. A different microbiome gene repertoire in the airways of cystic fibrosis patients with severe lung disease. Int J Mol Sci. 2017;18(8):1654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [54].Feigelman R, Kahlert CR, Baty F, et al. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Microbiome. 2017;5(1):20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [55].Metwally AA, Ascoli C, Turturice B, et al. Pediatric lung transplantation: dynamics of the microbiome and bronchiolitis obliterans in cystic fibrosis. J Heart Lung Transplant. 2020;39(8):824–834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [56].Dai W, Wang H, Zhou Q, et al. An integrated respiratory microbial gene catalogue to better understand the microbial aetiology of Mycoplasma pneumoniae pneumonia. Gigascience. 2019;8(8). DOI: 10.1093/gigascience/giz093 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [57].Bacci G, Taccetti G, Dolce D, et al. Untargeted metagenomic investigation of the airway microbiome of cystic fibrosis patients with moderate-severe lung disease. Microorganisms. 2020;8(7):1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [58].Nelson MT, Pope CE, Marsh RL, et al. Human and extracellular DNA depletion for metagenomic analysis of complex clinical infection samples yields optimized viable microbiome profiles. Cell Rep. 2019;26(8):2227–2240 e2225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [59].Pust MM, Wiehlmann L, Davenport C, et al. The human respiratory tract microbial community structures in healthy and cystic fibrosis infants. NPJ Biofilms Microbiomes. 2020;6(1):61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [60].Milani C, Casey E, Lugli GA, et al. Tracing mother-infant transmission of bacteriophages by means of a novel analytical tool for shotgun metagenomic datasets: mETAnnotatorX. Microbiome. 2018;6(1):145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [61].Milani C, Lugli GA, Fontana F, et al. METAnnotatorX2: a comprehensive tool for deep and shallow metagenomic data set analyses. mSystems. 2021;e0058321. DOI: 10.1128/mSystems.00583-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [62].Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [63].Langmead B, Wilks C, Antonescu V, et al. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics. 2019;35(3):421–432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [64].Chen Y, Ye W, Zhang Y, et al. High speed BLASTN: an accelerated MegaBLAST search tool. Nucleic Acids Res. 2015;43(16):7762–7768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [65].Caspi R, Billington R, Ferrer L, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 2016;44:D471–480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [66].Zhao Y, Tang H, Ye Y. RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data. Bioinformatics. 2012;28(1):125–126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [67].Ye Y, Choi JH, Tang H. RAPSearch: a fast protein similarity search tool for short reads. BMC Bioinformatics. 2011;12(1):159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [68].Vazquez-Baeza Y, Pirrung M, Gonzalez A, et al. EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience. 2013;2(16). DOI: 10.1186/2047-217X-2-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [69].Mallick H, Rahnavard A, McIver LJ, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [70].Duvallet C, Gibbons SM, Gurry T, et al. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun. 2017;8(1):1784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [71].Bisanz JE, Upadhyay V, Turnbaugh JA, et al. Meta-analysis reveals reproducible gut microbiome alterations in response to a high-fat diet. Cell Host Microbe. 2019;26(2):265–272 e264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [72].Greathouse KL, White JR, Padgett RN, et al. Gut microbiome meta-analysis reveals dysbiosis is independent of body mass index in predicting risk of obesity-associated CRC. BMJ Open Gastroenterol. 2019;6(1):e000247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [73].Mancabelli L, Tarracchini C, Milani C, et al. Multi-population cohort meta-analysis of human intestinal microbiota in early life reveals the existence of infant community state types (ICSTs). Comput Struct Biotechnol J. 2020;18:2480–2493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [74].Chen HW, Liu P-F, Liu Y-T, et al. Nasal commensal Staphylococcus epidermidis counteracts influenza virus. Sci Rep. 2016;6(1):27870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [75].Liu Q, Liu Q, Meng H, et al. Staphylococcus epidermidis contributes to healthy maturation of the nasal microbiome by stimulating antimicrobial peptide production. Cell Host Microbe. 2020;27(1):68–78 e65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [76].Esposito S, Polinori I, Rigante D. The gut microbiota-host partnership as a potential driver of kawasaki syndrome. Front Pediatr. 2019;7:124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [77].Campos J, Hernando M, Roman F, et al. Analysis of invasive haemophilus influenzae infections after extensive vaccination against H. influenzae Type b. J Clin Microbiol. 2004;42(2):524–529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [78].de Bentzmann S, Plesiat P. The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol. 2011;13(7):1655–1665. [DOI] [PubMed] [Google Scholar]
- [79].O’Gara JP. Into the storm: chasing the opportunistic pathogen Staphylococcus aureus from skin colonisation to life-threatening infections. Environ Microbiol. 2017;19(10):3823–3833. [DOI] [PubMed] [Google Scholar]
- [80].Weinberger B, Heck DE, Laskin DL, et al. Nitric oxide in the lung: therapeutic and cellular mechanisms of action. Pharmacol Therapeut. 1999;84(3):401–411. [DOI] [PubMed] [Google Scholar]
- [81].Sparacino-Watkins CE, Lai YC, Gladwin MT. Nitrate-Nitrite-Nitric Oxide pathway in pulmonary arterial hypertension therapeutics. Circulation. 2012;125(23):2824–2826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [82].England RJ, Homer JJ, Knight LC, et al. Nasal pH measurement: a reliable and repeatable parameter. Clin Otolaryngol Allied Sci. 1999;24(1):67–68. [DOI] [PubMed] [Google Scholar]
- [83].Silver S, Ji G. Newer systems for bacterial resistances to toxic heavy metals. Environ Health Perspect. 1994;102(3):107–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [84].Ghorani-Azam A, Riahi-Zanjani B, Balali-Mood M. Effects of air pollution on human health and practical measures for prevention in Iran. J Res Med Sci. 2016;21(1):65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [85].Briffa J, Sinagra E, Blundell R. Heavy metal pollution in the environment and their toxicological effects on humans. Heliyon. 2020;6(9):e04691. doi:ARTN. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [86].Adler CJ, Dobney K, Weyrich LS, et al. Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions. Nat Genet. 2013;45(4):450–455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [87].Kato I, Vasquez A, Moyerbrailean G, et al. Nutritional correlates of human oral microbiome. J Am Coll Nutr. 2017;36(2):88–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [88].Shea PR, Beres SB, Flores AR, et al. Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc Natl Acad Sci U S A. 2011;108(12):5039–5044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [89].Sommariva M, Le Noci V, Bianchi F, et al. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cell Mol Life Sci. 2020;77(14):2739–2749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [90].Wu BG, Segal LN, Britton RA. Lung microbiota and its impact on the mucosal immune phenotype. Microbiol Spectr. 2017;5(3). DOI: 10.1128/microbiolspec.BAD-0005-2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [91].O’Dwyer DN, Dickson RP, Moore BB. The lung microbiome, immunity, and the pathogenesis of chronic lung disease. J Immunol. 2016;196(12):4839–4847. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.